PBAX NASDAQ
Phoenix Biotech Acquisition Corp.
1W: -16.8%
1M: -47.5%
3M: -46.2%
1Y: -44.3%
$5.85
Last traded 2024-02-14 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$36.5M
52W Range4.12-12.8
Volume6,124
Avg Volume8,080
Beta0.04
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOChristopher B. Ehrlich
SectorFinancial Services
IndustryShell Companies
IPO Date2021-11-30
2201 Broadway
Oakland, CA 94612
US
Oakland, CA 94612
US
215 731 9450
About Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. currently lacks substantial business operations. The company's primary objective is to complete a strategic business combination, such as a merger, asset acquisition, share exchange, or other form of reorganization, with one or more suitable enterprises. Its focus is on identifying and integrating with a firm engaged in the healthcare or healthcare-related industries within the United States or Europe. This entity was established in 2021 and maintains its headquarters in Oakland, California.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| PHOENIX BIOTECH SPON | J-Other | 82,875 | — | 2021-10-08 |
| PHOENIX BIOTECH SPON | J-Other | 36,733 | $10.00 | 2021-10-08 |
| PHOENIX BIOTECH SPON | J-Other | 18,366 | $11.50 | 2021-10-08 |
| Ehrlich Christopher | J-Other | 82,875 | — | 2021-10-08 |
| Ehrlich Christopher | J-Other | 36,733 | $10.00 | 2021-10-08 |